Cancer Research includes companies working on scientific research aimed at understanding the causes, prevention, diagnosis, treatment, and potential cures for cancer. It includes many disciplines, from biology and genetics, to clinical trials and drug development, with the ultimate goal of improving cancer care and outcomes. Cancer research companies are developing life-saving treatments and diagnostics for a growing market in high demand. These companies constantly innovate, have a global reach, and form important strategic partnerships, which makes them appealing to investors looking for profits and supporting health progress.
Accuray GAAP EPS of $0.03 In-line, Revenue of $134.3M Beats by $12.79M
Bristol Myers' German Partner Evotec Plans Layoffs, Cites 'Challenging Revenues, Profitability'
Genprex Stock Slides 14% Following Reqorsa Study Updates
Gilead Wins FDA Nod for Liver Disease Drug
Puma Biotechnology Quickly Drops After Patents for Tagrisso Ruled Invalid
In-Depth Analysis: Merck & Co Versus Competitors In Pharmaceuticals Industry